Conducted in collaboration with The Avoca Group, based on an analysis of data provided by 76 varied sized pharmaceutical companies engaged in global drug development, a newly completed study from the Tufts Center for the Study of Drug Development says large sponsors have significantly longer and more variable process completion-to-contract stages than other companies.
For more from the study, click here.
Improving Relationships and Diversifying the Site Selection Process
April 17th 2025In this episode of the Applied Clinical Trials Podcast, Liz Beatty, co-founder and chief strategy officer, Inato, discusses a number of topics around site engagement including community-based sites, the role of technology in improving site/sponsor relationships, how increased operational costs are impacting the industry, and more.